Environment and sustainability

The environmental sustainability commitment of Macure Pharma and its partners unfolds in all the processes of the production cycle: From R&D to delivery, all the way through production, packaging development and marketing.

A constant goal is to reduce the environmental impact of its endeavours by cutting down on carbon emissions and integrating the use of natural resources. A goal in which our partners must be involved.

We believe that operating, as a responsible company that serves broader economic and societal interests will best create value by enabling us to attract and consolidate relations with customers, suppliers, and key stakeholders, while attracting and retaining our employees.

At Macure Pharma, we work to improve care for patients and deliver value for our stakeholders. Our ESG efforts are based on the requirements of the Danish Financial Statements Act, and we comply with relevant laws, standards and guidelines for reporting on ESG activities.

You can view Macure Pharma’s Environmental policy here:

Code of Conduct

In placing value on people, we see the expression and foundation of our culture and identity. We encourage and support human diversity in all its forms and expression of richness and as the source of long-term development.

Honesty and impartiality determine how Macure Pharma behaves. The aim is to encourage an open dialogue and always to seek a fair balance of the interests and legitimate expectations of all parties and those affected by our activities.

We recognize that our employees are the basis of our competitiveness and success. We therefore invest on an ongoing basis in the development and further professional training of our employees, both in the operational/technical field and in management, with a focus on increasing the performance of our employees and their contribution to continued improvement.

Internally, we work with well-being, health, safety and labour practices and diversity across the organisation, as well as organisational development. Externally, we work to create better life for patients and healthcare professionals through collaboration with patients and healthcare organisations.

Furthermore, we treat all employees equally irrespective of their gender, sexual orientation, nationality and place of residence, religion and political views.

Medical Aid

For the benefit of developing countries, we donate our excess medicine to hospitals in third world countries through the organisation Global Medical Aid. Currently, the medicine is donated to Afghanistan, Burkina Faso, Nepal and Sri Lanka in collaboration with the ministries of health and/or international organisations.

Most recently, our excess medicine has been donated to the Brothers of Charity in Rwanda.

Whistleblower Scheme

Who can report an incident?

Any former and current employees and business associates of Macure Pharma, can report any concerns, unethical or illegal, they may have under the Whistleblower Scheme.


What can be reported?
The types of concerns that may be raised under the Whistleblower Scheme are serious and sensitive concerns that could have an adverse impact on the operations and performance of Macure Pharma’s business, employees and other people interacting with the company. Such concerns include, without limitation:

  • Criminal offences, such as financial abuse, fraud, embezzlement, bribery, corruption or infringement
  • Serious or repeated breaches of internal procedures and company policies
  • Serious person-related episodes in the workplace, such as serious forms of violence, discrimination, harassment or other irregularities of a general or operational nature


How to report?
Make sure that the report contains all essential information and facts such as:

  • What does the matter concern?
  • Who are involved in the offence described in the report?
  • Where and when did the offence take place?
  • How has the reporter obtained the information?


Submit a report:

By e-mail to: reportincident@macurepharma.com


All whistleblowers are protected from any kind of retaliation, discriminatory or disciplinary action, including discharge, demotion, suspension, threats, or any other kind of harassment. Any such retaliation against a whistleblower is considered a serious breach of the Whistleblower Scheme. However, such protection shall not apply if the whistleblower maliciously makes any demonstrably false allegations.